🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Randomized study published in Lancet today, showing 62% EFS improvement with Nivo + SABR compared with SABR alone in early stage NSCLC. I-SABR is a promising TX option. awbs://authors.elsevier.com/c/1hRV5V-4XL3dJ IASLC MD Anderson Cancer Center The Lancet Albert Koong, MD PhD Stephen V Liu, MD

What a way to finish #RANZCR23!! Tuan Ha + Angela Allen a hard act to follow at the Gala with this 😂parody... good luck Prostate_doc as '24 Perth convenor! #radonc Jeff Michalski Sean Collins Prostate SBRT @ USF Health Peter Mac Radiation Oncology Sandra Turner Lucinda Morris Targeting Cancer Matthias Guckenberger Bill Loo MD PhD ⚡️☢️

🆕 insights from the STAMPEDE trial presented #ESMO2023: 5️⃣-year incidence of upper urinary tract obstruction significantly ⬇️ with prostate RT in all men with mHSPC❗️ #ProstateCancer Chris Parker Nick James also on @Prof-Nick-James.bsky.social ESMO - Eur. Oncology OncoAlert ESTRO ASTRO

Prof Jonathan Knisely talks about stereotactic radiosurgery for brain metastases at SIGA 2023 in Melbourne.

Great lectures at the SABR Symposium with Piet Ost and David Palma, MD, PhD in Melbourne.

Here is a slide presented by Fiona McDonald at #WCLC19 that teaches us how much normal lung tissue could be spared from ablative doses of SBRT if treatments didn't target the entire volume that a lung tumor moves through during free-breathing (conventional). #radonc

Thrilling update from #NSABP_B51 trial! 🎉 For cN+ patients turning ypN0 post-NAC, findings reveal no extra benefit from adjuvant regional nodal irradiation (RNI). Time for a rethink on regional node radiations in ypN0 cases! 🙌🏻 Let’s champion evidence-based practices! 💡

🚨🚨🚨 Rectal Cancer Tweetorial!! Rectal cancer is a highly heterogeneous disease with rapid evolution in practice. Let's review current data to generate a pragmatic, patient-centric, approach to management! #GI24 #GIonc #RadOnc Thank you ASCO for the opportunity!🙏🏽 1/

It is not the dissertation, tenure or retirement, but finding a good collaborator which is truly the important event in your career.

Just over a month until abstracts close for the 2024 ASM Perth 17-19 Oct! Submit your abstract in clinical radiology, interventional radiology, interventional neuroradiology or radiation oncology now. ⏩ ow.ly/rslX50QLgqx

NRG Oncology LU-002 #ASCOO24. Oligomet/oligoinduced #lungcancer RCT phase II, SoC +/- local consolidation #radiotherapy. NEGATIVE trial; n=215, 2-yr PFS = 36% in SoC systemic therapy arm 40% in LCT arm (HR 0.93). Puneeth Iyengar argues for biomarker selection. What next #radonc 🧐?

Amazing - did you watch this monumental engineering achievement??? SpaceX did it - grabbed a booster out of the air! And landed the ship

Amazing presentation by Piet @RANZCR ASM 2024

Prof Bill Loo impressive talk at #RANZCRASM2024

A game-changing radiation therapy technique called SABR cured Derek's lung cancer. Watch >> targetingcancer.com.au/dereks-story/ Thanks to Varian for their generous sponsorship of this important patient-centred story. #LungCancerAwarenessMonth

Does short-term ADT continue to show benefit after the negative results of NRG/RTOG 0815? Krishnan Patel, MD, MHS, Daniel E Spratt, Phuoc T. Tran, Daniel Krauss, Anthony D'Amico, and Paul Nguyen provide an up-to-date analysis suggesting continued benefit. tinyurl.com/redpatel

This is fantastic ! Great to help in shared decision making !

IBCG European Urology Sia Daneshmand, M.D. Patrick Hensley, MD Neema Navai Janet Kukreja Wes Kassouf Jonathan Rosenberg MD UroToday.com Stephen B. Williams, MD, MBA, MS, FACHE Thomas Flaig Bladder Cancer Advocacy Network Joan Palou Redorta Marek Babjuk Paolo Gontero Laura S. Mertens Laura Bukavina Sima Porten Bernie Bochner, MD Dr. Jason Efstathiou Albert Koong, MD PhD Jeffrey Holzbeierlein Cora Sternberg Benjamin Pradere Zach Klaassen Sarah P. Psutka MD MS Amanda Myers 📣 The message is clear: Offer bladder preservation up front. This is not “alternative” care - it’s informed, multidisciplinary, evidence-aligned care 🧵5/5 🔗 Full paper here, 50 days' free access courtesy European Urology European Urology Oncology authors.elsevier.com/a/1kzte14kpm0h…

Most papers fail because they fight the shape of good research writing. The best research papers shrink problems and expand implications. The middle of your paper should feel tight. Not sprawling. No one cares about your method... Until you make them care about the problem.

Such a well deserved standing ovation for Chris Booth and the Challenge trial. These data are quite powerful. Much stronger evidence than what we saw in plenaries today. #ASCO25